Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Rabeprazole sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rabeprazole sodium and what is the scope of rabeprazole sodium patent protection?

Rabeprazole sodium
is the generic ingredient in three branded drugs marketed by Teva Pharms Usa, Dr Reddys Labs Ltd, Fsc Therap, Breckenridge Pharm, Aurobindo Pharma Ltd, Lupin Ltd, Eisai Inc, Torrent Pharms Ltd, Kremers Urban Pharms, Amneal Pharms, and Mylan Pharms Inc, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for rabeprazole sodium. Twenty-three suppliers are listed for this compound.

Summary for Generic Name: rabeprazole sodium

Drug Master File Entries: see list29
Suppliers / Packagers: see list23
Bulk Api Vendors: see list52
Clinical Trials: see list958
Patent Applications: see list958
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:rabeprazole sodium at DailyMed

Pharmacology for Ingredient: rabeprazole sodium

Drug ClassProton Pump Inhibitor
Mechanism of ActionProton Pump Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL020973-001May 29, 2002DISCNYesNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL205761-001Feb 17, 2017ABRXNoNo► Subscribe► Subscribe
Kremers Urban Pharms
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL090678-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL078964-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL076885-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus